Frontier Science & Technology Research Foundation
Non-Profit & Charitable Organizations · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1371 Beacon St Ste 203, Brookline, Massa...Phone Number
(617) 632-2000Website
www.fstrf.comRevenue
<$5 MillionIndustry
About Frontier Science & Technology Research Foundation
Frontier Science & Technology Research Foundation Org Chart
Is Frontier Science & Technology Research Foundation your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Frontier Science & Technology Research Foundation, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Frontier Science & Technology Research Foundation launches new products
Congratulate Masked Content for being promoted to Masked Content at Frontier Science & Technology Research Foundation
Earning: See what the market has to say on Frontier Science & Technology Research Foundation recently announced quarterly report
Funding: Get notified immidiatlly once Frontier Science & Technology Research Foundation has new funding data
Click to see if Frontier Science & Technology Research Foundation had a recent Job posting/layoffs
Check if Frontier Science & Technology Research Foundation has recently received funding, and reach out quickly before it becomes old news!
Check out if Frontier Science & Technology Research Foundation is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Frontier Science & Technology Research Foundation
Find 3 more new buyers
Company Profile Activity
Activity Insights
Frontier Science & Technology Research Foundation is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Frontier Science & Technology Research Foundation is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Frontier Science & Technology Research Foundation.
Frontier Science & Technology Research Foundation Tech Stack
A closer look at the technologies used by Frontier Science & Technology Research Foundation
Most Recent Scoops
Frontier Science & Technology Research Foundation News & Media
Frontier Science and QualityMetric Collaborate on Worldwide Treatment Study in Youth Living with HIV
BOSTON, May 31, 2023 /PRNewswire/ -- Frontier Science, the Data Management Center for the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network, and QualityMetric, a leading global provider of patient-reported outcome (PRO) and clinical outcome assessment...Eight-year data from APHINITY study show Roche’s Perjeta-based regimen continues to reduce the risk of disease returning for people with HER2-positive early breast cancer
Basel, 14 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support Unit (IJB-CTSU) and Frontier Science Foundation (FS) today announced updated data from the phase III APHINITY study in HER2-positive early breast cancer. Results at 8.4 years median follow-up (101 months) showed the continued benefit of the combination of Perjeta® (pertuzumab), Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen), versus HLYNPARZA® (olaparib) reduced risk of death by 32% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Merck & Co., Inc., known as MSD outside the US and Canada, today announced further positive results from the OlympiA Phase III trial showed LYNPARZA® (olaparib) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) versus placebo in the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) high-risk human epidermal growth factor receptor 2 (HER2)-negative early breast cancer whoLynparza reduced recurrence risk in breast cancer
3 June 2021 22:00 BST Lynparza reduced the risk of cancer recurrence by 42% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer in OlympiA Phase III trial First medicine targeting BRCA mutations to show clinical benefit in adjuvant setting Results from the OlympiA Phase III trial showed AstraZeneca and MSD's Lynparza (olaparib) demonstrated a statistically significant and clinically meaningful improvement in invasive disease-free survival (iDFS) versus
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Frontier Science & Technology Research Foundation
Frontier Science & Technology Research Foundation Inc is a company that operates in the Non-Profit & Charitable Organizations industry. It employs 20to49 people and has 1Mto5M of revenue. The company is headquartered in Brookline, Massachusetts.... Read More